---
$id: https://graph.org.ai/products/commodity/51172019
$type: Product
source: UNSPSC
code: "51172019"
title: "Cyclobutyrol sodium"
class: "51172000"
classTitle: "Drugs used for gallbladder disease"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclobutyrol sodium

**UNSPSC Code**: 51172019
**Class**: [Drugs used for gallbladder disease](Drugs used for gallbladder disease.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the sodium form of a cholagogue or choleretic agent with the molecular formula C10H18O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8T4L120N6M, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy- but more generally known as cyclobutyrol, which bears US NIH Compound Identifier 72065. European Medicines Agency schedules Cyclobutyrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06851MIG. The term CYCLOBUTYROL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules cyclobutyrol in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOBUTYROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cyclobutyrol sodium under HS 29181985 and SITC 51392. As of Q4 2014, CYCLOBUTYROL SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CCC(C(=O)[O-])C1(CCCCC1)O.[NA+].

